Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
•
Gastrointestinal Cancers
What dose constraint do you use for the ostomy site when treating a patient with close/adjacent disease?
Answer from: Radiation Oncologist at Academic Institution
I treat it the same as the GI tract structure that it is part of, typically either the jejunum or colon.
Sign in or Register to read more
6685
Related Questions
Is there a role for radiation in palliating malignant small bowel obstruction?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
When would you opt to manage anal squamous cell carcinoma, HPV+ with surveillance vs adjuvant treatment following a trans-anal excision?
In a patient with metastatic colorectal cancer to the lung and liver, is there a role for liver directed therapy if the lung is not amenable to local therapy?
How would you treat a patient with synchronous node positive prostate cancer (T3bN1M0) and oligometastatic rectosigmoid cancer (T4aN1M1) with a solitary liver metastasis?
Do you always biopsy suspicious liver lesions if you have a biopsy from the pancreatic mass showing PDAC?
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
Is there any role for adjuvant chemoradiation in resected duodenal adenocarcinoma?
Would you offer pelvic re-irradiation in the setting of locally recurrent anal cancer in the presacral region?
What is the best way to proceed in anal cancer surveillance if PET avidity of the primary is reduced, but still avid at time point <6 months s/p chemo-RT?